Main menu:
CIP - Каталогизација у публикацији
Народна библиотека Србије, Београд
61
MD : Medical Data : medicinska revija = medical review / glavni i odgovorni urednik Dušan Lalošević. - Vol. 1, no. 1 (2009)- . - Zemun : Udruženje za kulturu povezivanja Most Art Jugoslavija ; Novi Sad : Pasterovo društvo, 2009- (Beograd : Scripta Internacional). - 30 cm
Dostupno i na: http://www.md-medicaldata.com. - Tri puta godišnje.
ISSN 1821-1585 = MD. Medical Data
COBISS.SR-ID 158558988
Authors
Saša Perić1, Vladan Đorđević2
1Klinika za gastroenterologiju i hepatologiju, Vojnomedicinska akademija, Beograd, Srbija / Clinic for Gastroenterology and Hepatology, The Military Medical Academy, Belgrade, Serbia
2Klinika za psihijatrijske bolesti „Dr Laza Lazarević“, Beograd, Srbija / Clinic for Psychiatric Disorders „Dr Laza Lazarević“, Belgrade, Serbia
The paper was received on 10.01.2017 / Accepted on 03.02.2017.
Correspondence to
Dr Vladan Đorđević, dr sci. med.
Klinika za psihijatrijske bolesti „Dr Laza Lazarević“ Beograd
Višegradska 26, 11 000 Beograd
Tel: +381 64 865 2536; +381 61 6116-475
e-mail: drvladandjordjevic@gmail.com
Abstract
In the treatment of diseases of digestive system accompanied by frequent diarrhea, probiotic monocultures are commonly used. Probiotics (bacteria and yeasts) are able to perform recolonization and renew symbiosis of the digestive system microflora. Probiotic yeasts Saccharomyces boulardii and Lactobacillus plantarum 299v (LP299v) areof particular importance in that sense. Since there are no data in Serbia concerning utilization and efficiency of probiotic cultures in the treatment of diseases of the digestive system, the aim of this study was to examine the experience of doctors at different levels of health care concerning clinical use of probiotics Saccharomyces boulardii monoculture (Bulardi®, Abela Pharm) and Lactobacillus plantarum 299v (LP299v) (Flobian®, Abela Pharm). The study compromised 60 respondents - doctors, employees in institutions of different levels of health care throughout Serbia. The results showed that the most patients were prescribed probiotics the doctors encountered in clinical use of probiotics, particularly the aforementioned probiotic monocultures. The most common indications were diarrheal syndrome, simultaneous antibiotic therapy and irritable colon. The reasons for their great use were the speed of action, and encouraging healthy microflora, without transfer of genetic material - if they were used with antibiotic therapy.
Key words
probiotics, Saccharomyces boulardii, Lactobacillus plantarum 299v (LP299v).
Sažetak
U lečenju bolesti digestivnog trakta koje su većinom praćene učestalim dijarejama, najčešće se koriste probiotske monokulture. Probiotici (bakterije i kvasnice) su sposobni da izvrše rekolonizaciju i obnove simbiozu mikroflore digestivnog sistema. Od naročitog značaja su probiotske kulture Saccharomyces boulardii i Lactobacillus plantarum 299v (LP299v). Budući da u Srbiji ne postoje podaci o stepenu korišćenja probiotskih monokultura i zapaženoj efikasnosti u lečenju bolesti digestivnog trakta, cilj ove studije bio je da se ispita iskustvo lekara na različitim nivoima zdravstvene zaštite u kliničkoj primeni probiotskih monokultura Saccharomyces boulardii (Bulardi®, Abela Pharm) i Lactobacillus plantarum 299v (LP299v) (Flobian®, Abela Pharm). Istraživanjem je obuhvaćeno 60 ispitanika - lekara, zaposlenih u ustanovama na različitim nivoima zdravstvene zaštite širom Srbije. Rezultati su pokazali da većina pacijenta sa kojima se lekari susreću u kliničkoj praksi koriste probiotike, a naročito pomenute probiotske monokulture. Najčešća područja primene bila su dijarejni sindrom, istovremena antibiotska terapija i iritabilni kolon. Razlozi za njihovu čestu upotrebu bili su brzina delovanja i podsticanje zdrave mikroflore, kao i nepostojanje transfera genetskog materijala, uz istovremenu primenu sa antibiotskom terapijom.
Ključne reči
probiotici, Saccharomyces boulardii, Lactobacillus plantarum 299v (LP299v).
References
UDK: 615.246.03
COBISS.SR-ID 230576396
PDF Perić S. and Đorđević V. •MD-Medical Data 2017;9(1): 057-061